These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 5018057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW, Skurzak HM, Klein E, Wigzell H.
    J Exp Med; 1972 Nov 01; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract] [Full Text] [Related]

  • 5. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS.
    J Natl Cancer Inst; 1974 Oct 01; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW, Skurzak HM, Klein E.
    Int J Cancer; 1972 Nov 01; 10(3):581-8. PubMed ID: 4128689
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH, Herberman RB, Nunn M, Soares N.
    J Natl Cancer Inst; 1973 Nov 01; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract] [Full Text] [Related]

  • 11. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr 01; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW, Anderson B, Wigzell H, Fenyö EM, Klein E.
    Int J Cancer; 1974 Jan 15; 13(1):91-104. PubMed ID: 4594340
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
    Kiessling R, Bataillon G, Lamon EW, Klein E.
    Int J Cancer; 1974 Nov 15; 14(5):642-8. PubMed ID: 4459279
    [No Abstract] [Full Text] [Related]

  • 17. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.
    Lamon EW, Wigzel H, Klein E, Andersson B, Skurzak HM.
    J Exp Med; 1973 Jun 01; 137(6):1472-93. PubMed ID: 4709269
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M, Pearson G, Pettigrew H, Redmon L, Orr T.
    Cancer Res; 1973 Nov 01; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.